25.03.2013
- Shire is to buy privately owned U.S. biotech firm SARcode Bioscience, paying $160 million upfront to win rights to a new drug in late-stage development for dry eye diseases. The...
27.04.2012
- Pharmaceutical firm Shire posted a 20% rise in first-quarter earnings on Thursday, just beating market expectations, as its drugs to treat hyperactivity again lifted market share...
22.12.2011
- GlaxoSmithKline executive German Pasteris is in charge of an Alzheimer's treatment that is years from reaching the market, if it ever does. But he already wants to make sure the...
